DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 91 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q2 2022. The put-call ratio across all filers is 0.35 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,410,135 | +2.8% | 196,425 | 0.0% | 0.74% | +79.1% |
| Q2 2023 | $2,345,315 | -10.7% | 196,425 | 0.0% | 0.41% | -24.1% |
| Q1 2023 | $2,626,202 | -37.9% | 196,425 | 0.0% | 0.54% | -40.3% |
| Q4 2022 | $4,227,066 | +7.4% | 196,425 | 0.0% | 0.91% | -0.8% |
| Q3 2022 | $3,934,000 | +11.9% | 196,425 | 0.0% | 0.92% | -2.1% |
| Q2 2022 | $3,516,000 | +75.0% | 196,425 | -3.0% | 0.94% | +85.2% |
| Q1 2022 | $2,009,000 | -41.1% | 202,500 | 0.0% | 0.51% | -23.6% |
| Q4 2021 | $3,412,000 | -29.0% | 202,500 | 0.0% | 0.66% | -12.2% |
| Q3 2021 | $4,805,000 | +4.2% | 202,500 | 0.0% | 0.75% | +32.5% |
| Q2 2021 | $4,611,000 | – | 202,500 | – | 0.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 9,663,645 | $95,863,000 | 39.92% |
| Atlas Venture Life Science Advisors, LLC | 8,201,638 | $81,360,000 | 10.29% |
| RA Capital Management | 6,060,090 | $60,116,000 | 1.31% |
| Boxer Capital, LLC | 1,189,943 | $11,804,000 | 0.61% |
| Samsara BioCapital, LLC | 202,500 | $2,009,000 | 0.51% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,086,449 | $20,698,000 | 0.46% |
| BVF INC/IL | 809,282 | $8,028,000 | 0.32% |
| Summit Rock Advisors, LP | 33,125 | $329,000 | 0.20% |
| Perceptive Advisors | 556,047 | $5,516,000 | 0.11% |
| Nan Fung Group Holdings Ltd | 11,445 | $114,000 | 0.05% |